Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Medivance
company
About
Medivance, Inc. develops, manufactures, and sells temperature management products to hospitals worldwide. The company’s flagship product,
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $16M
- Industries
- Biotechnology,Hospital,Manufacturing
- Founded date
- Jan 1, 1998
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Medivance, Inc. develops, manufactures, and sells temperature management products to hospitals worldwide. The company’s flagship product, the Arctic Sun Temperature Management System, enables clinicians to manage patient temperature in a noninvasive manner. It also offers clinical training in Targeted Temperature Management. The company was founded in 1998 and is headquartered in Louisville, Colorado with a European office in Den Hague, the Netherlands. As of November 10, 2011, Medivance, Inc. operates as a subsidiary of Bard Medical, Inc.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$39M
Medivance has raised a total of
$39M
in funding over 2 rounds. Their latest funding was raised on
Jul 27, 2007 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 27, 2007 | Series D | $23M | 1 | — | — | Detail |
| Jun 18, 2001 | Series B | $16M | 3 |
Cross Atlantic Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Medivance is funded by 3 investors.
Cross Atlantic Partners
and Nikko Synergy Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Cross Atlantic Partners
|
— | Series D |
|
|
— | Series B |
New England Partners
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
